WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
China exercises veto power in UN Security Council to uphold international justice: envoyAsian CL semifinal postponed in United Arab Emirates after flooding caused by heavy rainRed Sox's Tyler O'Neill left needing stitches after brutal collision with teammate Rafael DeversNelly Furtado wears NO underwear in racy laceUS Pentagon chief speaks with Chinese counterpart for first time since November 2022Xi inspects Changsha in central China's Hunan ProvinceChina's traffic authorities issue passenger vehicle safety reminderBeijing half marathon results under investigation after runners appear to hand win to Chinese starSupreme Court gives some military veterans more generous educational benefitsFormer Marine sentenced to 9 years in prison for firebombing California Planned Parenthood clinic